| Daisuke Sato, MD | |
|
1319 Punahou St # 741, Honolulu, HI 96826 | |
| (808) 983-6000 | |
| Not Available |
| Full Name | Daisuke Sato |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 1319 Punahou St # 741, Honolulu, Hawaii |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326779497 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | MDR-8341 (Hawaii) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Daisuke Sato, MD 1319 Punahou St # 741, Honolulu, HI 96826 Ph: () - | Daisuke Sato, MD 1319 Punahou St # 741, Honolulu, HI 96826 Ph: (808) 983-6000 |
News Archive
Researchers at University of Limerick and University Hospital Limerick have identified several new genetic biomarkers which better predict outcomes for patients with bowel/colorectal cancer. The research team identified genes that are predictors of cancer recurrence and can also help to identify a patients' suitability to specific types of chemotherapy.
Identifying diseases at an early, presymptomatic stage may offer the best chance for establishing proper treatment and improving patient outcomes. A new technique known as immunosignaturing harnesses the human immune system as an early warning sentry-one acutely sensitive to changes in the body that may be harbingers of illness.
Insulin pump therapy may be an effective alternative for people who cannot control their diabetes effectively using daily self-injections, show study findings.
U.S. drug reviewers might limit the use of a Seattle Genetics Inc's experimental blood cancer drug due to the narrow scope of its clinical trials. According to papers released Tuesday by the Food and Drug Administration (FDA), it requests an advisory panel to consider the drug, under the proposed trade name Adcetris known chemically as brentuximab vedotin, for use in previously treated patients with Hodgkin's lymphoma and anaplastic large cell lymphoma (ALCL).
Patients with pain caused by narrowed arteries in their legs have 37% more pain-free walking if they take naftidrofuryl (200mg three times a day) than those taking placebos, a Cochrane Review has found.
› Verified 5 days ago
Dr. Patricia Louise Heu, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 741 Sunset Ave, Honolulu, HI 96816 Phone: 808-733-9058 Fax: 808-733-9068 | |
Marissa Helene Fakaosita, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1319 Punahou St Fl 7, Honolulu, HI 96826 Phone: 808-369-1200 | |
Dr. Jeffrey K. Okamoto, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1319 Punahou St, Suite 757, Honolulu, HI 96826 Phone: 808-983-8387 Fax: 808-945-1570 | |
Eliot Nobuo Tomomitsu, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 321 N Kuakini St, Suite #201, Honolulu, HI 96817 Phone: 808-523-8611 | |
James A Griffith, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3288 Moanalua Rd, Honolulu, HI 96819 Phone: 808-432-0000 | |
Marivic Cristobal Raymundo, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 915 N King St, Honolulu, HI 96817 Phone: 808-848-1438 | |
Kelley Chinen Okimoto, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1319 Punahou St, Honolulu, HI 96826 Phone: 808-983-8387 |